Innovative Platform Miroculus offers the Miro Canvas platform, a compact, cartridge-based digital microfluidics system that automates complex NGS protocols, providing laboratories with accessible and easy-to-use solutions to accelerate genomic research and diagnostics.

Strong Market Growth With recent acquisitions and strategic partnerships, including the integration with Element Biosciences' AVITI System, Miroculus is positioned to expand its market share within the rapidly growing NGS and genomics automation sectors.

Financial Opportunity Generating between 50 million to 100 million USD in revenue with substantial funding of 45 million USD, Miroculus demonstrates a viable opportunity for sales teams to offer complementary automation tools or expansion into adjacent genomics applications.

Emerging Customer Base Targeting research laboratories and biotech companies focused on genomics and sequencing, Miroculus's user-friendly approach lower barriers for adoption, creating potential for upselling advanced automation solutions and integration services.

Technological Edge By leveraging advanced microfluidics, partnerships, and a commitment to simplifying complex protocols, Miroculus appeals to innovative labs seeking to enhance workflow efficiency, presenting sales opportunities for complementary biotech and automation tools.